Health Catalyst (NASDAQ:HCAT) has been assigned a consensus rating of “Buy” from the eight research firms that are presently covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $51.29.

A number of analysts have weighed in on HCAT shares. Svb Leerink started coverage on shares of Health Catalyst in a research note on Monday, August 19th. They set an “outperform” rating and a $55.00 target price on the stock. JPMorgan Chase & Co. started coverage on shares of Health Catalyst in a research note on Monday, August 19th. They set an “overweight” rating and a $50.00 target price on the stock. Leerink Swann started coverage on shares of Health Catalyst in a research note on Monday, August 19th. They set an “outperform” rating and a $55.00 target price on the stock. SunTrust Banks started coverage on shares of Health Catalyst in a research note on Monday, August 19th. They set a “buy” rating and a $53.00 target price on the stock. Finally, Piper Jaffray Companies assumed coverage on shares of Health Catalyst in a research note on Monday, August 19th. They set an “overweight” rating and a $47.00 target price on the stock.

Shares of NASDAQ HCAT remained flat at $$28.60 during midday trading on Tuesday. 237,264 shares of the company’s stock were exchanged, compared to its average volume of 401,742. The stock has a 50 day moving average price of $33.94. Health Catalyst has a 12-month low of $26.00 and a 12-month high of $49.85.

Health Catalyst (NASDAQ:HCAT) last posted its earnings results on Thursday, August 22nd. The company reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.34) by $0.13. The company had revenue of $36.80 million for the quarter, compared to the consensus estimate of $36.44 million. The firm’s revenue was up 60.1% compared to the same quarter last year. As a group, research analysts forecast that Health Catalyst will post -1.21 earnings per share for the current fiscal year.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.

Featured Story: What is the price-sales ratio?

Analyst Recommendations for Health Catalyst (NASDAQ:HCAT)

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.